KLYX

This brand name is authorized in Finland, Netherlands

Active ingredients

The drug KLYX contains a combination of these active pharmaceutical ingredients (APIs):

1 Docusate
UNII F05Q2T2JA0 - DOCUSATE SODIUM

Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity.

Read about Docusate
2 Sorbitol
UNII 506T60A25R - SORBITOL
Read about Sorbitol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A06AG10 Docusate sodium, incl. combinations A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 021442, 021467, 021480
Country: NL Z-Index G-Standaard Identifier(s): 12128619
Country: NL Z-Index G-Standaard, PRK Identifier(s): 1619

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈